FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced the successful completion of its fifth pan-European High Intensity Focused Ultrasound (“HIFU”) user group meeting, held in Turin, Italy. The meeting was hosted by the eminent Dr. Giovanni Muto of Ospedale San Giovanni Bosco (Giovanni Bosco Hospital).
